Pilot Project 2: Social Correlates of Variation in Intestinal and Oral Microbiome Among Hematopoietic Stem Cell Transplant Patients: A Geographic Exploration in the City of Chicago

试点项目 2：造血干细胞移植患者肠道和口腔微生物组变化的社会相关性：芝加哥市的地理探索

• 批准号: 10266786
• 负责人: Jonathan Moreira
• 金额: $ 3.89万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-24 至 2025-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10266786
• 关键词: Academic Medical Centers; Accreditation; Acute Graft Versus Host Disease; Address; Adult; African American; Allogenic; American; Antibiotics; Area; Attention; Benchmarking; Biological Markers; Caring; Cells; Censuses; Characteristics; Chicago; Cities; Clinic; Clinical; Collaborations; Communities; Community Surveys; Data; Databases; Development; Diet; Disease-Free Survival; Engraftment; Enrollment; Environment; Family; General Population; Geographic Locations; Geography; Health; Health Sciences; Health system; Hematology; Hematopoietic Stem Cell Transplantation; Hospitals; Human; Illinois; Income; Inequality; Inferior; Institution; Intestines; Latino; Low income; Malignant - descriptor; Malignant Neoplasms; Measures; Medical center; Medicine; Minority; Minority Groups; Neighborhoods; Oral; Outcome; Patient Recruitments; Patients; Pilot Projects; Play; Population; Positioning Attribute; Prospective Studies; Provider; Recurrent disease; Relapse; Research; Research Project Grants; Role; Sampling; Schedule; Side; Stem cell transplant; Stratification; System; Testing; Therapeutic Intervention; Time; Transplant Recipients; Transplantation; Treatment Efficacy; Underserved Population; Universities; Variant; cancer epidemiology; clinical care; clinical outcome measures; community engaged research; deprivation; design; follow-up; geographic difference; graft vs host disease; gut microbiome; gut microbiota; health equity; high risk; improved; indexing; individual patient; infection risk; innovation; low socioeconomic status; metropolitan; microbiome; microbiome composition; microbiome research; mortality; neutrophil; oral microbiome; patient population; patient stratification; post-transplant; programs; psychosocial; racial and ethnic; recruit; residential segregation; social; social culture; social epidemiology; socioeconomics; suburb; survival outcome

ABSTRACT There is increasing evidence that low levels of human intestinal microbiome diversity are associated with differential survival outcomes for various malignancies, with low levels of microbiome diversity associated with poorer outcomes. Amongst hematopoietic stem cell transplant patients, microbiome diversity is associated with risk of infection, disease relapse, and the development of graft vs. host disease. This has led to research on the effects of diet and antibiotic usage, which have been implicated in microbiome composition. Stem cell transplant patients from ethnic/racial minority groups and low socioeconomic status families have inferior survival outcomes relative to the general population. Insured status, socioeconomic and sociocultural factors may play a role in these disparate outcomes. One biomarker that may closely track these characteristics is the intestinal microbiome. This potentially clinically important biomarker, which has recently been benchmarked to the Shannon-Weaver diversity standards, has not been explored or compared among socially diverse patient populations. There has been little attention to psychosocial or neighborhood level environments that are proving to be of such importance in the social epidemiology of cancer. This Chicago Cancer Health Equity Collaborative (ChicagoCHEC) pilot research project is designed to lay the groundwork for an ecological analysis of variation in microbiome diversity. A large, diverse, and segregated city like Chicago has known disparate outcomes in various malignancies, and is an ideal urban center to explore the role of geographic variation in gut microbiome diversity. ChicagoCHEC community engaged research has laid the groundwork for successful patient recruitment through our affiliated medical centers, and the study team is in a strong position to undertake this pilot study as part of a larger microbiome research program. We propose an innovative, multi-institutional, prospective study evaluating serial changes in intestinal and oral gut microbiota amongst 50 hematopoietic stem cell transplant patients selected from two widely diverse areas that are each characteristic of large populations in the Chicago metropolitan area. The study will demonstrate the feasibility of analyzing the association of microbiome diversity with early clinical outcomes amongst stem cell transplant patients residing in the Chicago area. These findings are expected to better elucidate the role that area characteristics, as reflected by geographic location, may play in intestinal gut microbiome diversity.

摘要 越来越多的证据表明，低水平的人类肠道微生物组多样性与 各种恶性肿瘤的不同生存结局，与低水平的微生物组多样性相关， 更差的结果。在造血干细胞移植患者中，微生物组多样性与 感染、疾病复发和移植物抗宿主病发展的风险。这导致了对 饮食和抗生素使用的影响，这与微生物组组成有关。干细胞移植 来自少数民族/种族群体和低社会经济地位家庭的患者的生存结局较差 相对于一般人群。投保状况、社会经济和社会文化因素可能在以下方面发挥作用： 这些不同的结果。一个可以密切跟踪这些特征的生物标志物是肠道 微生物组这种潜在的临床重要生物标志物，最近已被基准化， Shannon-Weaver多样性标准尚未在社会多样性患者中进行探索或比较 人口。很少有人注意到社会心理或邻里水平的环境， 在癌症的社会流行病学中如此重要。这个芝加哥癌症健康公平合作组织 （芝加哥CHEC）试点研究项目旨在为变异的生态分析奠定基础 微生物组多样性。像芝加哥这样一个大的、多样化的、种族隔离的城市， 各种恶性肿瘤，是探索肠道微生物组地理变异作用的理想城市中心 多样性芝加哥CHEC社区参与的研究为成功的患者奠定了基础 通过我们的附属医疗中心进行招募，研究团队处于有利地位，可以承担这项工作 作为更大的微生物组研究计划的一部分进行试点研究。我们提出了一个创新的，多机构的， 一项前瞻性研究，评估了50名造血干细胞移植患者肠道和口腔肠道菌群的系列变化 细胞移植患者选自两个广泛不同的地区，每个地区都有大量人群的特点 在芝加哥大都会区。这项研究将证明分析的关联性的可行性， 微生物多样性与芝加哥干细胞移植患者早期临床结果 区预计这些研究结果将更好地阐明地理特征所反映的区域特征 位置，可能在肠道微生物组多样性中发挥作用。